Andrea L. Webber

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

Andrew X. Zhu, Richard S. Finn, Julien Edeline et al. · The Lancet Oncology · 2018 · 2.5K citations

Open-label Phase 2, Hepatology, Medicine +8

Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy

Răzvan Cristescu, Robin Mogg, Mark Ayers et al. · Science · 2018 · 2.3K citations

Checkpoint Blockade Immunotherapy, Immunology, Immune Cell Therapy +16

Epigenetic mechanisms underlying the imprinting of the mouse H19 gene.

Marisa S. Bartolomei, Andrea L. Webber, Mary E. Brunkow et al. · Genes & Development · 1993 · 484 citations · Full text

Histone Modifications, Methylation Domain, Igf2 Gene +18

Targeted disruption of semaphorin 3C leads to persistent truncus arteriosus and aortic arch interruption

Leonard Feiner, Andrea L. Webber, Christopher B. Brown et al. · Development · 2001 · 317 citations

PlexinA2 and semaphorin signaling during cardiac neural crest development

Christopher B. Brown, Leonard Feiner, Minmin Lu et al. · Development · 2001 · 220 citations

Cardiac Muscle, Cardiovascular Function, Congenital Heart Disease +16